Biosimilars Market 2022 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormone), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 263 | Published : June 2022 | SKU CODE : | | Format :

Request Sample

Biosimilars Market Definition

The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are proteins and are expressed in mammalian cell lines using cell lines and have been shown to offer no clinical difference compared to approved biologics. Biosimilars are made once the patent of the original biologic has expired.

Biosimilars are biological products produced to be identical to an approved biologic known as reference drugs. Biosimilars are expected to have similar safety and efficacy compared to the reference biologic product. The biosimilars market is segmented by product into recombinant non-glycosylated proteins and recombinant glycosylated proteins and other groups as shown above. Various types of biosimilars include human growth hormone, erythropoietin, monoclonal antibodies, insulin, interferon, granulocyte-colony stimulating factor, biosimilar monoclonal antibodies (mAbs) and others. Biosimilars are used for various applications such as oncology, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases, and others.

Biosimilars Market Size

The global biosimilars market reached a value of nearly $9,792.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 43.5% since 2015. The global biosimilars market size is expected to grow from $9,792.0 million in 2020 to $22,213.7 million in 2025 at a rate of 17.8%. The global biosimilars market size is then expected to grow at a CAGR of 17.5% from 2025 and reach $49,786.4 million in 2030.  

Growth in the historic period in the biosimilars market resulted from increase in cancer prevalence, strong economic growth in emerging markets, increase in pharmaceutical R&D expenditure, increased healthcare expenditure, government initiatives, strong pipeline of drugs, low cost of biosimilars, increase in patent expiration. The market was restrained by pricing pressures from regulators, challenges due to regulatory changes, low healthcare access, lack of awareness on biosimilars among primary care physicians and specialists and reimbursement challenges.

Going forward, increasing prevalence of cancer, increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF), rise in healthcare expenditure, high potential of emerging economies, technology advances, high penetration of the biosimilar drugs, rising aging population, and increase in healthcare access will drive the growth in the vaccines market. Factors that could hinder the growth of the market in the future include high costs of drugs, high cost of drug development with threat of failure, and coronavirus pandemic.

Biosimilars Market Drivers

The key drivers of the biosimilars market include:

Increasing Prevalence Of Cancer

The rise in the number of cancer cases across the globe contributed to the growth of the biosimilars market during the historic period. The prevalence rate in oncology is observed to be highest amongst the elder population. Cancer is the second major cause of death accounting for around 1 in 6 deaths due to cancer worldwide. According to the American Cancer Society, there are 1.8 million new cancer cases and 0.60 million deaths in the US in 2020, that is about 4,950 new cases and more than 1,600 deaths each day. About 70% of deaths from cancer occur in low- and middle-income countries. G-CSF is a class of growth factor which produces white blood cells in the bone marrow to minimize the risk of infection and sepsis. In cancer patients, G-CSF accelerates recovery and reduces mortality from neutropenia after chemotherapy for cancer. It can also reduce infection after certain forms of treatment for cancer. Pegfilgrastim-jmdb (Fulphila), Trastuzumab-pkrb (Herzuma), Trastuzumab-anns (Kanjinti), Bevacizumab-awwb (Mvasi), Filgrastim-aafi (Nivestym), Trastuzumab-dkst (Ogivri), Trastuzumab-dttb (Ontruzant), are some biosimilars approved by US-FDA. Therefore, the increasing prevalence of cancer is expected to drive the growth of the biosimilars market.

Biosimilars Market Restraints

The key restraints on the biosimilars market include:

High Costs Of Drugs

The high cost is a key factor limiting the growth of the biosimilars market. Improved chemotherapy administration is responsible for the rise in instant medical expenses in breast cancer patients receiving primary prophylactic (PP) G-CSF. According to a study conducted by the American Journal of Managed Care, PPG-CSF administration in the first chemotherapy class was associated with a 57% increase in total Medicare costs during the study period, despite a fall in medical costs for neutropenia. Around 42% of the increase can be attributed to the rise in the costs of chemotherapy. Each shot of PPG-CSF costs more than $250. Therefore, the high cost is expected to hinder the growth of the biosimilars market.

Biosimilars Market Trends

Major trends influencing the biosimilars market include:

Robust Research & Development

The biosimilars market is witnessing robust research and development activities. These research and development activities have led to increasing success rates in clinical trials. Research and development is being carried out by market leaders in the biosimilars market as they continuously strive to make breakthroughs in the market in the form of new and effective drugs. For instance, as of October 2020, Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies is anticipating FDA approval for a Biologics License Application (BLA) for ROLONTIS, a novel, long-acting granulocyte colony-stimulating factor (G-CSF), an indication for the treatment of neutropenia in patients receiving myelosuppressive anti-cancer drugs. Also, many drugs are in pipeline under development by some of the major companies such as Amgen, Biocon. .  In June 2020, Pfizer, an American multinational pharmaceutical company, received approval from the US Food and Drug Administration to introduce its biosimilar drug for lowering the incidence of infection as manifested by febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs.

In May 2021, Zydus Cadila, launched the world’s first biosimilar antibody-drug conjugate of trastuzumab emtansine. The biosimilar, which uses Genentech/Roche’s trastuzumab emtansine (Kadcyla®) as the reference product, will be marketed under the name Ujvira®. In March 2020, AzarGen Biotechnologies (Pty) Ltd., a South Africa-based biotechnology company, in collaboration with iBio, Inc., a USA-based biotechnology company initiated its development activities of rituximab biosimilar.  AzarGen Biotechnologies is expected to utilize FastPharming System developed by iBio, Inc. to produce rituximab in plants.

Demand For Biosimilars In The Treatment Of Neutropenia

The demand for biosimilars to treat chemotherapy-related neutropenia in cancer patients has been increasing owing to the cost effectiveness of the treatment and equivalent efficiency of the biosimilars to the biological drugs. For instance, according to a comparative study conducted to understand the cost efficiency of filgrastim biosimilars, it was concluded that prophylaxis or treatment of febrile neutropenia with Zarzio is cost-efficient under all possible treatment scenarios relative to Neupogen and Neulasta. It was seen that the cost of Neupogen treatment ranged from $151 (1 day) to $2114 (14 days), compared to $112 and $1575 for Zarzio, thus yielding potential cost savings from $39 to $540 for the latter.

Opportunities And Recommendations In The Biosimilars Market

Opportunities –The top opportunities in the biosimilars market segmented by type will arise in monoclonal antibodies segment, which will gain $7,305.0 million of global annual sales by 2025. The top opportunities in the biosimilars market segmented by application will arise in oncology segment, which will gain $5,922.2 million of global annual sales by 2025. The biosimilars market size will gain the most in the USA at $5,575.5 million.

Recommendations –To take advantage of the opportunities, the business research company recommends the biosimilar companies to focus on robust research and development, on strategic partnerships for new product development, focus on biosimilars in the treatment of neutropenia, expand in emerging markets and in developed markets with high biosimilar adoption, set up authorized distributors and sales representatives, expand in countries offering research incentives, scale up through merger and acquisition activity, provide competitively priced offerings in low-income countries, direct marketing, focus on increasing awareness, targeting hospitals and pharmacies to spread awareness, focus on cancer patients and on the aging population

Biosimilars Market Segmentation

The biosimilars market is segmented by type and by application
By Type–
The biosimilars market is segmented by type into
    • a) Monoclonal Antibodies
    • b) Insulin
    • c) Erythropoietin
    • d) Granulocyte-Colony Stimulating Factor
    • e) Other Hormones
    • f) Others
The monoclonal antibodies segment was the largest segment of the biosimilars market segmented by type, accounting for 35.9% of the total in 2020. Going forward, the erythropoietin segment is expected to be the fastest growing segment in the biosimilars market segmented by type, at a CAGR of 26.5% during 2020-2025.
By Application –
The biosimilars market is segmented by application into
    • a) Oncology
    • b) Chronic and Autoimmune Diseases
    • c) Growth Hormone Deficiency
    • d) Infectious Diseases
    • e) Other Applications
The chronic and autoimmune diseases segment was the largest segment of the biosimilars market segmented by application, accounting for 47.1% of the total in 2020. Going forward, the infectious diseases segment is expected to be the fastest growing segment in the biosimilars market segmented by application, at a CAGR of 24.6% during 2020-2025.
By Geography – The biosimilars market is segmented by geography into
    • o North America
      • •  USA
      o Asia Pacific
      • •  China
      • •  Australia
      • •  India
      • •  Japan
      • •  Indonesia
      • •  South Korea
    • o South America
      • •  Brazil
      o Western Europe
      • •  UK
      • •  Germany
      • •  France
      o Eastern Europe
      • •  Russia
      o Middle East
      o Africa
Western Europe was the largest region in the global biosimilars market, accounting for 71.06% of the total in 2020. It was followed by the North America, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the global biosimilars market will be Middle East and Africa where growth will be at CAGRs of 131.8% and 119.7% respectively during 2020-2025. These will be followed by South America and Eastern Europe, where the markets are expected to register CAGRs of 117.7% and 106.4% respectively during 2020-2025

Biosimilars Market Competitive Landscape

Major Competitors are:

  • Amgen
  • Pfizer
  • Novartis AG
  • Viatris
  • Celltrion, Inc.
  • Other Competitors Include:

  • Samsung Bioepis Co., Ltd.
  • Biocon
  • Elli Lilly and Company
  • Dr. Reddy's Laboratories
  • Coherus Biosciences
  • Wuxi biologics
  • Shanghai Henlius biotech
  • Innovent Biologics
  • Hisun Pharma
  • 3SBio
  • Beijing ShuangLu Pharmaceuticals
  • Qilu Pharmaceutical
  • Shanghai Fosun Pharmaceuticals
  • Mylan
  • Kyowa Hakko Kirin
  • Takeda
  • Mitsubishi Tanabe
  • AGC Biologics
  • Bio-Thera
  • Sandoz Pty Ltd
  • Apotex Pty Ltd
  • Cadila Pharmaceuticals
  • BiosanaPharma
  • GlaxoSmithKline
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Sanofi
  • Fresenius Kabi
  • Napp Pharmaceuticals Coherus Biosciences, Inc.
  • Mundipharma Deutschland GmbH & Co. KG
  • Microgen
  • Geropharm
  • Valenta
  • NovaMedica
  • SynBio
  • Roche
  • Rani Therapeutics
  • Emisphere Technologies, Inc.
  • Enteris BioPharma
  • Allena Pharmaceuticals
  • Abbvie
  • Johnson & Johnson
  • Biogen Inc.
  • Aché
  • Eurofarma
  • Teva Pharmaceuticals
  • Oramed Pharmaceuticals
  • Entera Bio
  • Julphar
  • Hikma Pharmaceuticals
  • Coherus Biosciences Inc.
  • BIOPHARMA-MEA
  • NeoTX
  • AID Genomics Limited
  • Altis Biologics
  • Cipla Medpro
    1. Table Of Contents

      1. Biosimilars Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Application

      7. Biosimilars Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Type

      7.2.1. Monoclonal Antibodies

      7.2.2. Insulin

      7.2.3. Erythropoietin

      7.2.4. Granulocyte-Colony Stimulating Factor

      7.2.5. Other Hormone

      7.2.6. Others

      7.3. Segmentation By Application

      7.3.1. Oncology

      7.3.2. Chronic and Autoimmune Diseases

      7.3.3. Growth Hormone Deficiency

      7.3.4. Infectious Diseases

      7.3.5. Others

      8. Biosimilars Market Trends And Strategies

      8.1. Robust Research & Development

      8.2. Demand For Biosimilars In The Treatment Of Neutropenia

      8.3. Growing Mergers And Acquisitions

      8.4. Revised FDA Regulations To Facilitate Biosimilar Drug Development

      8.5. Large Number Of Strategic Partnerships

      8.6. Increasing Investments In Biosimilars Market

      9. Impact Of COVID-19 On The Biosimilars Market

      9.1. Clinical Trial Delays

      9.2. Impact On Major Biosimilars Companies In The Market

      9.3. Impact On Rituximab Biosimilars

      9.4. How Leading Rituximab Biosimilars Companies Handled COVID

      9.5. Impact Of COVID-19 On Major Pegfilgrastim Biosimilar Market Player Biocon Biologics

      9.6. Future Outlook

      10. Global Biosimilars Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3.Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Biosimilars Market Segmentation

      11.1. Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. Biosimilars Market, Regional And Country Analysis

      12.1. Global Biosimilars Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Biosimilars Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Biosimilars Market

      13.1. Asia-Pacific Biosimilars Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulatory Bodies

      13.1.6. Regulations

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.4.Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6.Asia-Pacific Biosimilars Market: Country Analysis

      13.7. China Biosimilars Market

      13.8.China Biosimilars Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Background Information

      13.8.4. Government Initiatives

      13.8.5. Regulatory Bodies

      13.8.6. Regulations

      13.8.7. Major Associations

      13.8.8. Taxes Levied

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9.China Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.11. China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Biosimilars Market

      13.14. India Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.16. India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Biosimilars Market

      13.19. Japan Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.21. Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Biosimilars Market

      13.24. Australia Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.26. Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Biosimilars Market

      13.29. Indonesia Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.31. Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Biosimilars Market

      13.34. South Korea Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.36. South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Biosimilars Market

      14.1.Western Europe Biosimilars Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulatory Bodies

      14.1.6. Regulations

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3.Western Europe Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.4. Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Biosimilars Market: Country Analysis

      14.7. UK Biosimilars Market

      14.8. UK Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.10. UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Biosimilars Market

      14.13. Germany Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.15. Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Biosimilars Market

      14.18. France Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.20. France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Biosimilars Market

      15.1. Eastern Europe Biosimilars Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulatory Bodies

      15.1.6. Regulations

      15.1.7. Taxes Levied

      15.1.8. Corporate Tax Structure

      15.1.9. Investments

      15.1.10. Major Companies

      15.2. Eastern Europe Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.4. Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Biosimilars Market: Country Analysis

      15.7. Russia Biosimilars Market

      15.8. Russia Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.9. Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.10. Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Biosimilars Market

      16.1.North America Biosimilars Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulatory Bodies

      16.1.6. Regulations

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate tax structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3.North America Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.4. North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Biosimilars Market: Country Analysis

      16.7. USA Biosimilars Market

      16.8. USA Biosimilars Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulatory Bodies

      16.8.6. Regulations

      16.8.7. Major Associations

      16.8.8. Taxes Levied

      16.8.9. Corporate Tax Structure

      16.8.10.Investments

      16.8.11. Major Companies

      16.9. USA Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.11. USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Biosimilars Market

      17.1. South America Biosimilars Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulatory Bodies

      17.1.6. Regulations

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.4. South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Biosimilars Market: Country Analysis

      17.7. Brazil Biosimilars Market

      17.8. Brazil Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.9. Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.10. Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Biosimilars Market

      18.1. Middle East Biosimilars Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background information

      18.1.4. Government Initiatives

      18.1.5. Regulatory Bodies

      18.1.6. Regulations

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3.Middle East Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.4. Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Biosimilars Market

      19.1.Africa Biosimilars Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background information

      19.1.4. Government Initiatives

      19.1.5. Regulatory Bodies

      19.1.6. Regulations

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Biosimilars Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3.Africa Biosimilars Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.4. Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Biosimilars Market Competitive Landscape

      20.1. Company Profiles

      20.2. Amgen Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Pfizer Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Novartis AG

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Viatris Inc.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Celltrion, Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Biosimilars Market

      21.1. Celltrion Acquired Takeda Pharmaceuticals

      21.2. ChrysCapital Acquired Stakes In Intas Pharmaceuticals

      21.3. Amgen Acquired Japanese JV with Astellas

      21.4. True North Acquired Stake In Biocon Biologics Ltd.

      21.5. PAG Acquired Hisun BioRay Bio-pharmaceutical Co., Ltd.

      21.6. Pfizer Inc. Acquired Array BioPharma Inc.

      21.7. Samsung Bioepis Enters Into An Agreement With C-Bridge Capital

      21.8. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech

      21.9. Kashiv Pharma Acquired Adello Biologics

      21.10. Bristol-Myers Squibb Acquired Celgene Corporation

      21.11. Takeda Pharmaceutical Company Limited Acquired Shire Plc

      21.12. Amneal Pharmaceuticals Merge With Impax Laboratories

      21.13. Biocon Merged With Sandoz

      21.14. Sun Pharmaceutical Industries Limited Acquired Zenotech Laboratories

      22. Biosimilars Market Opportunities And Strategies

      22.1. Global Biosimilars Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global Biosimilars Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global Biosimilars Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Biosimilars Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Biosimilars Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Biosimilars Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Biosimilars Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Biosimilars Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Asia-Pacific Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 12: Asia-Pacific Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 13: Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 14: Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 15: Asia-Pacific Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 16: Asia-Pacific Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 17: China Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 18: China Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 19: China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: China Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 22: China Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 23: India Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 24: India Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 25: India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 26: India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 27: India Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 28: India Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 29: Japan Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 30: Japan Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 31: Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 32: Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 33: Japan Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 34: Japan Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 35: Australia Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 36: Australia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 37: Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: Australia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 40: Australia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 41: Indonesia Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 42: Indonesia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 43: Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 44: Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 45: Indonesia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 46: Indonesia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 47: South Korea Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 48: South Korea Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 49: South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: South Korea Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 52: South Korea Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 53: Western Europe Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 54: Western Europe Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 55: Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 56: Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 57: Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 58: Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 59: UK Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 60: UK Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 61: UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 62: UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 63: UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 64: UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 65: Germany Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 66: Germany Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 67: Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 68: Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 69: Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 70: Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 71: France Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 72: France Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 73: France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 74: France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 75: France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 76: France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 77: Eastern Europe Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 78: Eastern Europe Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 79: Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 80: Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 81: Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 82: Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 83: Russia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 84: Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 85: Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 86: Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: North America Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 89: North America Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 90: North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 91: North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 92: North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: USA Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 95: USA Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 96: USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 97: USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 98: USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 99: USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 100: South America Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 101: South America Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: Brazil Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 107: Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 108: Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 109: Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 110: Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 111: Middle East Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 112: Middle East Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 113: Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 114: Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 115: Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 116: Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 117: Africa Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Table 118: Africa Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 119: Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 120: Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 121: Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 122: Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 123: Global Biosimilars Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 124: Global Biosimilars Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 125: Global Biosimilars Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 126: Global Biosimilars Market Size Gain ($ Million), Segmentation By Product, 2020 – 2025
    • Table 127: Biosimilars - Market Data Sources

    List Of Figures

      Figure 1: Global Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 2: Global Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 3: Global Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 4: Global Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 5: Global Biosimilars Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 6: Global Biosimilars Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Asia-Pacific Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 8: Asia-Pacific Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 9: Asia-Pacific Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Asia-Pacific Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: China Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 12: China Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: China Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: China Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: India Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 16: India Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: India Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: India Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: Japan Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 20: Japan Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: Japan Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: Japan Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Australia Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Australia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Indonesia Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Indonesia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Indonesia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Indonesia Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: South Korea Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 32: South Korea Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: South Korea Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: South Korea Biosimilars Market, Segmentation By Types, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: Western Europe Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 36: Western Europe Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: Western Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Western Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: UK Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 40: UK Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: UK Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: UK Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Germany Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Germany Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Germany Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Germany Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: France Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 48: France Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: France Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: France Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Eastern Europe Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Eastern Europe Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Eastern Europe Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Eastern Europe Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Russia Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: Russia Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Russia Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: North America Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 59: North America Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 60: North America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: North America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: USA Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 63: USA Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 64: USA Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: USA Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: South America Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 67: South America Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 68: South America Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: South America Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: Brazil Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: Brazil Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Brazil Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 73: Middle East Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 74: Middle East Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 75: Middle East Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 76: Middle East Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: Africa Biosimilars Market, Historic, 2015 – 2020, $ Million
    • Figure 78: Africa Biosimilars Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Africa Biosimilars Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 80: Africa Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: Global Biosimilars Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    Global Contract Research And Manufacturing Services (CRAMS) Market Size, Forecasts, And Opportunities – Includes CRAMS Market Overview
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Vaccines Market 2021 - By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Others), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Ophthalmology Drugs Market - By Type (Antiglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Prescription Type (OTC Drugs, Prescription Drugs), By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Drug Variation (Branded Drugs, Generic Drugs), And, By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Gene Therapy Global Market Report 2022 – By Gene Type (Antigen, Cytokine, Suicide Gene), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases), By End Users (Hospitals, Homecare, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Cell Therapy Global Market Report 2022 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Microbiome Global Market Report 2022 – By Type (Fecal Microbiota Transplantation (FMT), Microbiome drugs), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Technology (Genomics, Proteomics, Metabolomics) – Market Size, Trends, And Global Forecast 2022-2026
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)